Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage

Gut

Volumn 46, Issue 5, 2000, Pages 725-731

  Kimmings, A N ^a   Obertop, H ^a   Gouma, D J ^a   Van Deventer, S J H ^a   Rauws, E A J ^a   Huibregtse, K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Endotoxin; Endotoxin binding proteins; Obstructive jaundice

Indexed keywords

BINDING PROTEIN; CD14 ANTIGEN; CYTOKINE; ELASTASE; ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 8; LACTOFERRIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BILIARY TRACT DRAINAGE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENDOSCOPIC THERAPY; ENDOTOXEMIA; HUMAN; INFLAMMATION; OBSTRUCTIVE JAUNDICE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STENT;

ANTIGENS, CD14; BILE DUCT NEOPLASMS; CARRIER PROTEINS; CHOLESTASIS; CYTOKINES; DRAINAGE; ENDOSCOPY, GASTROINTESTINAL; ENDOTOXINS; HUMANS; INTERLEUKIN-8; LEUKOCYTE COUNT; NEUTROPHIL ACTIVATION; PREOPERATIVE CARE;

EID: 0034022709     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.5.725     Document Type: Article

References (46)

1. 1 Diamond T, Rowlands BJ. Review article. Endotoxaemia in obstructive jaundice. HPB Surg 1991;4:81-94.
2. 2 Deitch EA, Sittig K, Berg R, et al. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990;159:79-84.
3. 3 Ding JW, Andersson R, Soletsz V, et al. Obstructive jaundice impairs reticuloendothelial function and promotes bacterial translocation in the rat. J Surg Res 1994;57:238-45.
4. 4 Bemelmans MHA, Greve JW, Gouma DJ, et al. Cytokines TNF and IL-6 in biliary obstruction in mice. Hepatology 1992;15:1132-6.
5. 5 Pain JA. Reticulo-endothelial function in obstructive jaundice. Br J Surg 1987;74:1091-4.
6. 6 Bemelmans MHA, Greve JW, Gouma DJ, et al. Increased concentrations of tumor necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. Gut 1996;38: 447-53.
7. 7 Ding JW, Andersson R, Soltez V, et al. The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. Eur Surg Res 1993;25:11-19.
8. 8 Thompson RLE, Hoper M, Diamond T, et al. Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice. Br J Surg 1990;77:1229-32.
9. 9 Ding JW, Andersson R, Stenram U, et al. Effect of biliary decompression on reticuloendothelial function in jaundiced rats. Br J Surg 1992;79:648-52.
10. 10 Gouma DJ, Coelho JCU, Schlegel JF, et al. The effect of preoperative internal and external biliary drainage on mortality of jaundiced rats. Arch Surg 1987;122:731-4.
11. 11 Greve JW, Maessen JG, Tiebosch T, et al. Prevention of postoperative complications in jaundiced rats. Ann Surg 1991;212:221-7.
12. 12 Mathison JC, Tobias PS, Wolfson E, et al. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of Gram-negative LPS. J Immunol 1992;149:200-6.
13. 13 Wright SD. CD14 and innate recognition of bacteria. J Immunol 1995;155:6-8.
14. 14 Marra MN, Wilde CG, Collins MS, et al. The role of bactericidal/permeability increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992;148:532-7.
15. 15 Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988;207:39-41.
16. 16 Lai ECS, Mok FPT, Fan ST, et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 1994;81:1195-8.
17. 17 Karsten Th M, Allema JH, Reinders ME, et al. Preoperative biliary drainage, bile colonisation and postoperative complications in patients with pancreatic head tumors: an analysis in 241 consecutive patients. Eur J Surg 1996;162: 881-8.
18. 18 Motte S, Deviere J, Dumonceau J-M, et al. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991;101:1374-81.
19. 19 Karsten Th M, Coene PPLO, van Gulik TM, et al. Morphologic changes of the extrahepatic bile ducts during obstruction and subsequent decompression by endoprosthesis. Surgery 1992;111:562-8.
20. 20 Bode C, Fukui H, Bode JC. "Hidden" endotoxin in plasma of patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 1993;5:257-62.
21. 21 Van de Poll T, Jansen J, Levi M, et al. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994;180:1985-8.
22. 22 Van de Poll T, Jansen J, van Leenen D, et al. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis 1993;168:955-60.
23. 23 White ML, Ma JK, Birr CA, et al. Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA. J Immunol Methods 1994; 167:227-37.
24. 24 Mészáros K, Aberle S, White ML, et al. Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat inactivated sera. Infect Immun 1995;63: 363-5.
25. 25 Nuijens JH, Abbink JJ, Wachtvogel YT, et al. Plasma elastase α1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992;119:159-68.
26. 26 Hack CE, Paardekoper J, Eerenberg AJ, et al. A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 1251-C3 instead of 1251-C3a. J Immunol Meth 1988;107:77-84.
27. 27 Dentener MA, Francot GJM, Smit FT, et al. Presence of bactericidal/permeability increasing protein in disease; detection by ELISA. J Infect Dis 1995;171:739-43.
28. 28 Blamey SL, Fearon KCH, Gilmore WH, et al. Prediction of risk in biliary surgery. Br J Surg 1983;70:535-8.
29. 29 Tobias PS, Soldau K, Gegner JA, et al. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995;270:10482-8.
30. 30 Wurfel MM, Kunitake ST, Lichenstein HS, et al. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994;180:1025-35.
31. 31 Krüger C, Schütt C, Obertacke U, et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 1991;85:297-301.
32. 32 Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 1995;181:1743-54.
33. 33 Möhlen MAM von der, Kimmings AN, Wedel NI, et al. The effect of a recombinant bactericidal/permeability increasing protein on cytokine release in experimental endotoxemia in humans. J Infect Dis 1995;172:144-51.
34. 34 Froon AHM, Dentener MA, Greve JWM, et al. Lipopolysaccharide toxicity-regulating proteins in bacteremia. J Infect Dis 1995;171:1250-7.
35. 35 Lantz M, Gullberg E, Nilsson E, et al. Characterization in vitro of a human tumor necrosis factor binding protein. J Clin Invest 1990;86:1396-402.
36. 36 Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxemia. J Clin Invest 1992;88:533-6.
37. 37 Ballinger AB, Woolley JA, Ahmed M, et al. Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction. Gut 1998;42:555-9.
38. 38 Rosen HR, Winkle PJ, Kendall BJ, et al. Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography. Dig Dis Sci 1997;42:1290-4.
39. 39 Kanazawa A, Kinoshita H, Hirohashi K, et al. Concentrations of bile and serum endotoxin and serum cytokines after biliary drainage for acute chlangitis. Osaka City Medical Journal 1997;43:15-27.
40. 40 Puntis MC, Jiang WG. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice. J Gastroenterol Hepatol 1996;11:7-13.
41. 41 Kimura F, Miyazaki M, Suwa T, et al. Hyperactive cytokine response after partial hepatectomy in patients with biliary obstruction. Eur Surg Res 1998;30:259-67.
42. 42 Kimmings AN, Deventer van SJH, Rauws EAJ, et al. The systemic inflammatory response in acute cholangitis and after subsequent treatment. Eur J Surg 2000, in press.
43. 43 Baggiolini M, Moser B, Clark-Lewis I. Interleukin-8 and related chemotactic cytokines. The Giles Filley lecture. Chest 1994;105:95-8.
44. 44 Hechtman DH, Cybulsky MI, Fuchs HJ, et al. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991;147: 883-92.
45. 45 Swain MG, Tjandra K, Kanwar S, et al. Neutrophil adhesion is impaired in rat model of cholestasis. Gastroenterology 1995;109:923-32.
46. 46 Yanagitani K, Kubota Y, Tsuji K, et al. Influence of biliary obstruction on neutrophil chemotaxis. J Gastroenterol 1998;33:536-40.